Literature DB >> 25167161

Changes in the levels of cytokines in both diabetic/non-diabetic type I children living in a moderate altitude area in Saudi Arabia.

Gamal Allam1, Adnan A Alsulaimani, Hamed Alghamdi, Hameed Alswat, Burhan M Edrees, Iftikhar Ahmad, Amre Nasr.   

Abstract

The aim of the present study was to investigate the possible effects of living in moderate altitude area on pro/anti-inflammatory cytokines profile (IFN-γ, TNF-α, IL-6, IL-1β, IL-10, and IL-4) among type I diabetic (T1D) and non- T1D children compared with those living at sea level area. A prospective clinical study was carried out at pediatric outpatient endocrine clinics in Taif City, which is a moderate altitude area in Saudi Arabia, that stands about 1800-2000 meters above sea-level; and in Mecca City, which is a sea level area, that lies in the middle west of Saudi Arabia. Hemoglobin A1c (HbA1c) percentage was estimated and cytokine measurements were performed in sera by flow cytometry using Cytometric Bead Array (CBA) technology. In this study we included 600 children who were consecutively enrolled (sex and age were matched). The HbA1c was statistically significantly higher in children living in moderate altitude compared to those living at sea level (overall p<0.001). Furthermore, T1D patients had higher values of serum cytokine levels (IFN-γ, TNF-α, IL-6, IL-1β, IL-4, and IL-10) in comparison to non-T1D control group (overall p<0.001). In conclusion, the data of the present study clearly showed that in both T1D and non-T1D children, moderate altitude-natives expressed high HbA1c and both pro-and anti-inflammatory cytokines. Type I diabetic children living in moderate altitude or at sea level showed elevated levels of IFN-γ, TNF-α, IL-6, IL-1β, IL-4, and IL-10 than control subjects. Glycemic control in non-diabetic children was affected by living in moderate altitude, however, HbA1c significantly increased in diabetic children living in moderate altitude.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25167161      PMCID: PMC4174425          DOI: 10.1089/ham.2014.1001

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  63 in total

1.  Operation Everest II: metabolic and hormonal responses to incremental exercise to exhaustion.

Authors:  P M Young; J R Sutton; H J Green; J T Reeves; P B Rock; C S Houston; A Cymerman
Journal:  J Appl Physiol (1985)       Date:  1992-12

2.  [The relationship between occupational stress and serum glycosylated hemoglobin A1c level].

Authors:  Yan Yang; Shan-fa Yu; Kai-you Jiang
Journal:  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi       Date:  2011-12

Review 3.  Adventure travel and type 1 diabetes: the complicating effects of high altitude.

Authors:  Patricia L Brubaker
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

4.  Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.

Authors:  M A Berman; C I Sandborg; Z Wang; K L Imfeld; F Zaldivar; V Dadufalza; B A Buckingham
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

5.  Acclimatization to high altitude increase muscle sympathetic activity both at rest and during exercise.

Authors:  R S Mazzeo; G A Brooks; G E Butterfield; D A Podolin; E E Wolfel; J T Reeves
Journal:  Am J Physiol       Date:  1995-07

Review 6.  Glucose metabolism in chronic lung disease.

Authors:  H P Sauerwein; A M W J Schols
Journal:  Clin Nutr       Date:  2002-10       Impact factor: 7.324

7.  Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.

Authors:  K Amirshahrokhi; A R Dehpour; J Hadjati; M Sotoudeh; M Ghazi-Khansari
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-11       Impact factor: 4.219

8.  Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

Authors:  M G Cavallo; P Pozzilli; C Bird; M Wadhwa; A Meager; N Visalli; A J Gearing; D Andreani; R Thorpe
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

9.  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells.

Authors:  P Ghezzi; C A Dinarello; M Bianchi; M E Rosandich; J E Repine; C W White
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

10.  Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field.

Authors:  D Soszynski; W Kozak; C A Conn; K Rudolph; M J Kluger
Journal:  Neuroendocrinology       Date:  1996-05       Impact factor: 4.914

View more
  1 in total

1.  Suppressing Interferon-γ Stimulates Microglial Responses and Repair of Microbleeds in the Diabetic Brain.

Authors:  Stephanie Taylor; Eslam Mehina; Emily White; Patrick Reeson; Kevin Yongblah; Kristian P Doyle; Craig E Brown
Journal:  J Neurosci       Date:  2018-09-10       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.